Elligo Joins Efforts To Expand COVID-19 Risk Screening, Testing


Applied Clinical Trials

Elligo Health Research, a healthcare-enabling research organization, is working with Verily to support the Project Baseline COVID-19 Program. The program is a collaboration with the California Governor’s office, federal, state and local public health authorities, to expand COVID-19 risk screening and testing. Elligo is one of the few companies to project-manage and staff drive-by COVID-19 test sites with three initial sample-collection sites that launched Monday, March 16 in San Mateo County and Santa Clara County. Additional locations are expected in the coming weeks.

Elligo is also providing a full spectrum of solutions to help manage COVID-19 testing efforts on-site and off-site, including access to staff and partnerships with national labs to support needs once samples are collected; site-specific recommendations on workflow, standard operating procedures, and protocols; and a support team for current medical staff, among other services.  

For more, click here. 


Related Videos
Greg Ball, Founder, ASAP Process Consulting image credit screen shot from video
Janice Chang, CEO, TransCelerate BioPharma @ video screenshot.
Related Content
© 2024 MJH Life Sciences

All rights reserved.